(redirected from new drug)
Also found in: Dictionary, Thesaurus, Medical.


1. any synthetic, semisynthetic, or natural chemical substance used in the treatment, prevention, or diagnosis of disease, or for other medical reasons
2. a chemical substance, esp a narcotic, taken for the pleasant effects it produces
3. drug on the market a commodity available in excess of the demands of the market
Collins Discovery Encyclopedia, 1st edition © HarperCollins Publishers 2005


Any substance used internally or externally as a medicine for the treatment, cure, or prevention of a disease.
A narcotic preparation.
McGraw-Hill Dictionary of Scientific & Technical Terms, 6E, Copyright © 2003 by The McGraw-Hill Companies, Inc.


principle of evil. [Zoroastrianism: Leach, 325]
See: Evil
Allusions—Cultural, Literary, Biblical, and Historical: A Thematic Dictionary. Copyright 2008 The Gale Group, Inc. All rights reserved.


The interpretation of drugs in your dreams depends on the relationship you have with drugs in your daily life and whether they are doctor prescribed or not. If you are a drug user, then the drugs are an extension of what you normally do, and you need to look at the other details of your dream to get a good interpretation. However, if you use drugs rarely or never, then this dream could represent a need to get well, to escape from daily stress, and a desire to get quick relief. The drugs could be suggesting a need for healing and getting in balance. Your unconscious mind may be suggesting outrageous things in hopes that you get the message to “have fun, dream dreams, and get out of your own head!” Please keep in mind that the purpose of dreams is to raise our consciousness and to assist us in having better lives. The message in the dream about drug use is most likely not encouraging you to use drugs but it may represent a need to feel better or get better.
Bedside Dream Dictionary by Silvana Amar Copyright © 2007 by Skyhorse Publishing, Inc.
References in periodicals archive ?
In groups L, G, A, N, and C, which account for 16 (14.7%), 13 (11.9%), 9 (8.2%), 9 (8.2%), and 8 (7.3%) of the new drugs, respectively, the balance between disease burden and the new drug introduction has been questioned.
The committee oversees pharmacy policies and procedures and reviews the clinical merits, safety, effectiveness and clinical value of new drugs as they come to market.
But only one new drug in the last few years has gone on to the next level to be tested for environmental risks through chronic ecotoxicity tests, according to Florian Zielinski, a chemist at the FDA Center for Drug Evaluation and Research.
Efforts are under way to produce new drugs, but one of the most efficacious candidates has run into economic and manufacturing obstacles (8.9).
The clinical research (IND) phase--representing the time from beginning of human trials to the new drug application (NDA) submission that seeks permission to market the drug--is by far the longest portion of the drug development cycle and can last from 2 to 10 years.
Moreover, consumer groups fret that there's inherent pressure when industry provides so much funding--about 18 percent of the agency's total budget last year, and half the budget for new drug reviews.
Dr Peter Barrett-Lee, a consultant oncologist at Cardiff's Velindre Hospital - and breast cancer expert - said the new drug was 'very promising.'
According to a 2001 Tufts University study--funded by the industry--it costs an average of $800 million to get a single new drug to market.
Its products are used by pharmaceutical, biotechnology and medical device companies to create new drug applications, reports, proposals and technical documentation.
Only a relatively small amount of the presumed $400 billion, however, will actually go for new drug coverage.
These university researchers obtained the R&D costs of 68 randomly selected new drugs from a survey of 10 pharmaceutical firms, and used the data to estimate the average pre-tax cost of new drug development.
In contrast, the FDA through the Pediatric Rule issued in 1998 required mandatory testing and enforcement through FDA refusal to approve a new drug if a manufacturer did not conduct those studies.